Solara Active Pharma Sciences Limited has informed the Exchange about the Schedule of Investors/Analysts call to be held on Friday, May 15, 2026, at 15.00 (IST), to discuss the Company's audited financial results for the quarter and year ended March 31, 2026
SOLARA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Solara Active Pharma Sciences has scheduled an analysts/investors conference call for Friday, May 15, 2026, at 3:00 PM IST to discuss the company's audited financial results for Q4 and the full year ended March 31, 2026. The call will feature the Founder & Non-Executive Director Arun Kumar, MD & CEO Sandeep Rao, and CFO Sarat Kumar. The company has provided dial-in numbers for participation. This is a routine disclosure filed with BSE and NSE (scrip codes: 541540, 890202) as per listing obligations.
This is a standard pre-result announcement. The scheduled call indicates that Q4FY26 and FY26 results are expected to be released soon, and retail investors can dial in to hear the management's commentary on performance. No material news is conveyed by this filing itself.